Literature DB >> 6851935

Ca2+-calmodulin-dependent phosphorylation of soluble and nuclear proteins in the rat ovary.

E T Maizels, R A Jungmann.   

Abstract

Studies were undertaken to determine if calmodulin-regulated Ca2+-dependent protein kinase system(s) exist in the prepubertal rat ovary. Phosphorylation studies were performed with ovarian cytosol, calmodulin-depleted cytosol, and nuclear extracts. In vitro phosphorylation of endogenous substrate proteins was accomplished by incubation of tissue fractions with [gamma-32P]ATP followed by electrophoretic separation and autoradiographic demonstration of phosphorylated proteins. Calmodulin-dependent phosphorylations of a cytosol protein, mol wt, 95,000, and of three nuclear proteins in the mol wt range of 50,000-60,000, were established by demonstrating: Ca2+ requirement; inhibition by the phenothiazine derivative chlorpromazine; and dependence upon addition of exogenous calmodulin to the calmodulin-depleted cytosol, or to the nuclear extract. These findings demonstrate the presence of rat ovarian cytosol and nuclear Ca2+-calmodulin-dependent protein kinase activities capable of recognizing endogenous substrate proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851935     DOI: 10.1210/endo-112-6-1895

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Role of Ca2+ activation and bilobal structure of calmodulin in nuclear and nucleolar localization.

Authors:  Richard Thorogate; Katalin Török
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

2.  Non-histone chromatin proteins in beef thyroid: distinct phosphorylation patterns of several protein kinases.

Authors:  S Levasseur; T Poleck; Y Friedman; G Burke
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

3.  Three-dimensional intracellular calcium gradients in single human burst-forming units-erythroid-derived erythroblasts induced by erythropoietin.

Authors:  R V Yelamarty; B A Miller; R C Scaduto; F T Yu; D L Tillotson; J Y Cheung
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.